Observational data has demonstrated that omega-3 fatty acids, particularly alpha-linolenic acid (ALA), in plasma levels can be linked to slower disease progression in amyotrophic lateral sclerosis (ALS) patients. According to Kjetil Bjornevik, MD, PhD, from the Harvard T.H. Chan School of Public Health in Boston, ALS patients with high levels of ALA had a 50%
According to the phase III MAESTRO-NASH trial, the investigational agent resmetirom has demonstrated positive results in treating nonalcoholic steatohepatitis (NASH). The study found that the drug resolved liver biopsy findings in NASH more often than the placebo. While only 10% of the placebo patients achieved resolution of inflammation, ballooning, and disease activity, the rate was
A new large cohort study has shown that a third of intraocular lens (IOL) implants for nontraumatic glaucoma in children required reoperation for visual axis opacification (VAO) within 5 years, most often in eyes that did not have anterior vitrectomy. The study highlights the need for long-term monitoring of children with primary IOL implantation. Study